Risk factor
Good trading liquidity
Profitability factor
Favourable analyst view
In Guru Portfolios
Manager | Fund | Portfolio Weight (%) | Change |
|---|---|---|---|
| Daniel Loeb | Third Point | 4.8% | -5.71% |
| Steven Cohen | Point72 Asset Management, L.P. | 0.3% | +0.04% |
| Kenneth Griffin | CITADEL ADVISORS LLC | 0.0% | +0.02% |
About
Somnigroup International Inc., operating as Somni, leads the field in advanced sleep technology and holistic wellness solutions. They engineer groundbreaking products specifically designed to elevate sleep quality. Their approach seamlessly integrates scientifically validated methods, intelligent technology, and data-driven insights to optimize sleep patterns and foster overall well-being.
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBIT
Target Price
The average target price of SGI is 90.4 and suggests 45.1% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre